News | June 21, 2022
Medix Biochemica acquires Bioresource Technology
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Group 4 Medulloblastoma is a rare disease that mostly affects pediatric patients, in which aberrant SRC signaling was identified as a hallmark of the disease
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
To address the preventive & primary healthcare delivery gaps in India
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Subscribe To Our Newsletter & Stay Updated
